{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:40:07Z","timestamp":1775760007132,"version":"3.50.1"},"reference-count":59,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Autoimmune liver disorders in childhood include autoimmune hepatitis (AIH) and AIH\/sclerosing cholangitis overlap syndrome (henceforth referred to as autoimmune sclerosing cholangitis, ASC). These inflammatory liver disorders are characterised histologically by interface hepatitis, biochemically by elevated transaminase levels, and serologically by autoantibodies and increased levels of immunoglobulin G. AIH is particularly aggressive in children and progresses rapidly unless immunosuppressive treatment is started promptly. With appropriate treatment, 80% of patients achieve remission and long-term survival. For non-responders and difficult-to-treat patients, novel and more effective therapeutic approaches are sought. ASC responds to the same treatment used for AIH in regards to parenchymal inflammation, but bile duct disease progresses in about 50% of cases, leading to a worse prognosis and a higher liver transplantation requirement; moreover, it has a high recurrence rate after transplant. Progression of liver disease and recurrence after transplant are more common in patients with associated poorly controlled inflammatory bowel disease. Though the mechanisms underlying the pathogenesis of liver autoimmunity are not fully understood, genetic and environmental factors are likely to be involved. A deeper understanding of the pathogenesis of these conditions will contribute to the development of novel treatments, aimed ultimately at the restoration of tolerance to liver-derived antigens.<\/jats:p>","DOI":"10.1136\/archdischild-2013-303848","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T04:42:06Z","timestamp":1378269726000},"page":"1012-1017","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["Paediatric autoimmune liver disease"],"prefix":"10.1136","volume":"98","author":[{"given":"Giorgina","family":"Mieli-Vergani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"key":"2023090603500796000_98.12.1012.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.009"},{"key":"2023090603500796000_98.12.1012.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.69"},{"key":"2023090603500796000_98.12.1012.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.08.002"},{"key":"2023090603500796000_98.12.1012.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250308"},{"key":"2023090603500796000_98.12.1012.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2004.11.009"},{"key":"2023090603500796000_98.12.1012.6","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32092"},{"key":"2023090603500796000_98.12.1012.7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1233529"},{"key":"2023090603500796000_98.12.1012.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006283222601"},{"key":"2023090603500796000_98.12.1012.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.10.007"},{"key":"2023090603500796000_98.12.1012.10","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"2023090603500796000_98.12.1012.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(94)70253-5"},{"key":"2023090603500796000_98.12.1012.12","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.10.019"},{"key":"2023090603500796000_98.12.1012.15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005176-199310000-00016","article-title":"Neonatal sclerosing cholangitis in two siblings: a category of progressive intrahepatic cholestasis","volume":"17","author":"Baker","year":"1993","journal-title":"J Ped Gastroenterol Nutr"},{"key":"2023090603500796000_98.12.1012.16","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.23984"},{"key":"2023090603500796000_98.12.1012.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.044"},{"key":"2023090603500796000_98.12.1012.18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.031732"},{"key":"2023090603500796000_98.12.1012.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.06.001"},{"key":"2023090603500796000_98.12.1012.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.020"},{"key":"2023090603500796000_98.12.1012.21","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24562"},{"key":"2023090603500796000_98.12.1012.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300611"},{"key":"2023090603500796000_98.12.1012.23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(85)90348-4","article-title":"Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis","volume":"2","author":"Vergani","year":"1985","journal-title":"Lancet"},{"key":"2023090603500796000_98.12.1012.24","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/S0168-8278(02)80564-5","article-title":"Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis","volume":"36","author":"Underhill","year":"2002","journal-title":"J Hepatol"},{"key":"2023090603500796000_98.12.1012.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180435"},{"key":"2023090603500796000_98.12.1012.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"2023090603500796000_98.12.1012.27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"2023090603500796000_98.12.1012.28","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.524206"},{"key":"2023090603500796000_98.12.1012.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000304456.84552.13"},{"key":"2023090603500796000_98.12.1012.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000239735.87111.ba"},{"key":"2023090603500796000_98.12.1012.31","first-page":"438","article-title":"Long-term daily oral treatment with prednisolone in children with autoimmune liver disease does not affect final adult height","volume":"44","author":"Samaroo","year":"2006","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2223\/1371","article-title":"Type 1 autoimmune hepatitis in children and adolescents: assessment of immunosuppressive treatment withdrawal","volume":"81","author":"Ferreira","year":"2005","journal-title":"J Pediatr (Rio J)"},{"key":"2023090603500796000_98.12.1012.33","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.34","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.119"},{"key":"2023090603500796000_98.12.1012.35","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.3.319"},{"key":"2023090603500796000_98.12.1012.36","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000232331.93052.dd"},{"key":"2023090603500796000_98.12.1012.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80065-8"},{"key":"2023090603500796000_98.12.1012.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.046"},{"key":"2023090603500796000_98.12.1012.39","doi-asserted-by":"crossref","unstructured":"Woynarowski M Nemeth A Baruch Y . Budesonide vs prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr 2013 Jun 27. pii: S0022-3476(13)00658-6. doi: 10.1016\/j.jpeds.2013.05.042. [Epub ahead of print].","DOI":"10.1016\/j.jpeds.2013.05.042"},{"key":"2023090603500796000_98.12.1012.40","doi-asserted-by":"crossref","unstructured":"Mieli-Vergani G Vergani D . Budesonide for juvenile autoimmune hepatitis Not yet. J Pediatr 2013 Aug 8. pii: S0022-3476(13)00823-8. doi: 10.1016\/j.jpeds.2013.06.064. [Epub ahead of print].","DOI":"10.1016\/j.jpeds.2013.06.064"},{"key":"2023090603500796000_98.12.1012.41","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30991"},{"key":"2023090603500796000_98.12.1012.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.02.024"},{"key":"2023090603500796000_98.12.1012.43","doi-asserted-by":"publisher","DOI":"10.1080\/0891693021000056721"},{"key":"2023090603500796000_98.12.1012.44","first-page":"555","article-title":"Outcome and survival in childhood onset autoimmune sclerosing cholangitis and autoimmune hepatitis: a 13\u2005years follow-up study","volume":"46","author":"Scalori","year":"2007","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.10.028"},{"key":"2023090603500796000_98.12.1012.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06478-7"},{"key":"2023090603500796000_98.12.1012.47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jhep.2002.35339","article-title":"Autoimmunity after liver transplantation","volume":"36","author":"Vergani","year":"2002","journal-title":"Hepatology"},{"key":"2023090603500796000_98.12.1012.48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"40","author":"Mieli-Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"2023090603500796000_98.12.1012.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.05.030"},{"key":"2023090603500796000_98.12.1012.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01717.x"},{"key":"2023090603500796000_98.12.1012.51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21152"},{"key":"2023090603500796000_98.12.1012.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00801.x"},{"key":"2023090603500796000_98.12.1012.53","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.021004225.x"},{"key":"2023090603500796000_98.12.1012.54","first-page":"147","article-title":"Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens","volume":"2","author":"Sakaguchi","year":"2000","journal-title":"Rev Immunogenet"},{"key":"2023090603500796000_98.12.1012.55","doi-asserted-by":"publisher","DOI":"10.1038\/336176a0"},{"key":"2023090603500796000_98.12.1012.56","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.151.2.1039","article-title":"Cyclosporin A-induced autoimmune disease in mice","volume":"151","author":"Bucy","year":"1993","journal-title":"J Iimmunol"},{"key":"2023090603500796000_98.12.1012.57","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.4049\/jimmunol.162.11.6926","article-title":"Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants","volume":"162","author":"Wu","year":"1999","journal-title":"J Immunol"},{"key":"2023090603500796000_98.12.1012.58","first-page":"1","article-title":"Cyclosporin A-induced autoimmunity: the result of defective de novo T- cell development","volume":"44","author":"Damoiseaux","year":"1998","journal-title":"Folia Biol"},{"key":"2023090603500796000_98.12.1012.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.11.002"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-303848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:52:21Z","timestamp":1693997541000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-303848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,11,12]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/archdischild-2013-303848"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-303848","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}